Schedule 13D ownership disclosure

GRAPHITE BIO INC

Security class unavailable · CUSIP: 38870X104

Event date: 2023-11-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
25.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-279834
Form type
SC 13D/A
Filer
LENZ Therapeutics, Inc.
CIK
CIK 1815776
Filed
Nov 17, 2023
Reporting period
Nov 14, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub